Dr Majid Kazmi



  • Not Fee assured

About me

I am the Lead Cancer Clinician at Guy's & ST Thomas' NHS Foundation Trust with a focus on high quality healthcare. I am a key opinion leader in stem cell transplantation and chair the UK group for transplantation in auto-immune disorders such as Multiple sclerosis or Crohn's disease. I have undertaken the greatest number of these transplants in the UK. I am a key opinion leader in Myeloma and lead several national studies. I am also involved in the UK guidelines group for myeloma.

Areas of interest

Myeloma; General haematology; Haematological oncology; Marrow or stem cell transplantation (surgery); UK lead for stem cell transplantation in multiple sclerosis and other auto-immune disorders

Medical secretaries

About me
My qualifications & training
My private practice
Consultant's practices
Information for healthcare professionals

Information for healthcare professionals (Bupa patients only, last 12 months)

Procedures completed

  • X0004

    Clinical supervision and planning for delivery of chemotherapy cycle 1 - 28 days - (5-50)

    London Bridge Hospital (5-50)

  • X0003

    Clinical supervision and planning for delivery of chemotherapy cycle 1 - 21 days - (5-50)

    London Bridge Hospital (5-50)

  • W3650

    Diagnostic aspiration and trephine biopsy of bone marrow, including analysis - (1-5)

    London Bridge Hospital (1-5)

  • XR917

    Peripherally inserted central venous catheters (PICCs) under x-ray guidance - (1-5)

  • X3590

    Intravenous infusion (as sole procedure) - (1-5)

    London Bridge Hospital (1-5)

Report this page Edit details Print page

The information contained on Finder is submitted by consultants, therapists and healthcare services, and these third parties declare it to be correct and compliant with their relevant regulatory bodies' standards and codes of conduct. We're unable to guarantee the accuracy of all of the information provided.

You can find out more about the information on Finder and our website terms of use here.